Influence of Genetic Polymorphisms on Clopidogrel Response and Clinical Outcomes in Patients with Acute Ischemic Stroke CYP2C19 Genotype on Clopidogrel Response - Han, Yan; Lv, Hui‐Hui; Liu, Xu; Dong, Qiang; Yang, Xiao‐Li; Li, Shi‐Xu; Wu, Shuai; Jiang, Jian‐Ming; Luo, Zheng; Zhu, De‐Sheng; Zhang, Yi; Zheng, Yi; et al. (CNS neuroscience & therapeutics, 2015)
Keywords: Aged; Biomarkers, Pharmacological; Brain Ischemia - drug therapy; Brain Ischemia - genetics; Cardiology; Clinical outcomes; Clopidogrel; CYP2C19; Cytochrome P-450 CYP2C19 - genetics; Female; Follow-Up Studies; Genotype; Genotype & phenotype; Humans; Ischemic stroke; Male; Original; Platelet Aggregation Inhibitors - therapeutic use; Platelet Function Tests; Polymorphism, Single Nucleotide; Prospective Studies; Random Allocation; Stroke; Stroke - drug therapy; Stroke - genetics; The VerifyNow P2Y12 test; Ticlopidine - analogs & derivatives; Ticlopidine - therapeutic use; Treatment Outcome; Clopidogrel; Ischemic stroke; CYP2C19; The VerifyNow P2Y12 test